Welcome to our dedicated page for Atlanta Braves Holdings SEC filings (Ticker: BATRK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings page for Atlanta Braves Holdings, Inc. (Nasdaq: BATRK) provides access to the company’s official regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Atlanta Braves Holdings is a Nevada corporation whose business consists primarily of the Atlanta Braves Major League Baseball Club and a mixed-use real estate portfolio that includes The Battery Atlanta and related properties such as Pennant Park.
Through this page, users can review current and historical filings, including Form 8-K reports that describe material events. Recent 8-K filings for BATRK have covered topics such as quarterly financial results and performance stock unit awards granted under the company’s omnibus incentive plan. These documents offer detail on segment performance for Baseball and Mixed-Use Development, the company’s definition and use of Adjusted OIBDA, and certain compensation arrangements for named executive officers.
Investors can also use this section to locate periodic reports such as Forms 10-K and 10-Q when filed, which typically contain segment disclosures, risk factor discussions, capital structure information and reconciliations of non-GAAP measures to GAAP results. In addition, the filings page is a resource for tracking governance-related disclosures, equity incentive plans and other items that may appear in registration statements or proxy materials.
Stock Titan enhances these filings with AI-powered summaries that highlight key points, explain complex sections in simpler terms and help users quickly identify information related to revenue sources, segment results, non-GAAP metrics and executive compensation. Real-time updates from EDGAR ensure that new BATRK filings, including any future Forms 4 for insider transactions, are made available promptly for review and analysis.
Atlanta Braves Holdings, Inc. (BATRK) – Form 144 filing discloses a proposed insider sale of the company’s Series C common stock.
Shares to be sold: 30,000. Aggregate market value: $1,365,000. Approximate sale date: 06/20/2025. Broker: UBS Financial Services Inc., 11 Madison Ave., New York, NY 10010. Exchange: NASDAQ. Total Series C shares outstanding: 51,297,110, making the proposed transaction roughly 0.06 % of the class.
The seller proposes to dispose of the shares that were acquired by exercising stock options on 06/20/2025; the consideration paid was cash. The filing also details prior sales within the last three months by Derek Schiller at the same address (755 Battery Avenue SE, Atlanta, GA 30339):
- 72,505 shares sold on 06/11/2025 for gross proceeds of $3,117,767.01
- 40,000 shares sold on 06/18/2025 for gross proceeds of $1,760,000.00
Cumulatively, 112,505 shares have already been sold in the past quarter for $4,877,767.01, representing roughly 0.22 % of the outstanding Series C shares. Including the newly-noticed 30,000 shares, total potential dispositions reach 142,505 shares (≈0.28 % of the class) with an aggregate value in excess of $6.2 million.
The signer affirms no knowledge of undisclosed material adverse information and, if applicable, compliance with Rule 10b5-1 trading plans. No remarks, plan-adoption date, or additional issuer details were supplied in the filing.
Atlanta Braves Holdings, Inc. (Ticker: BATRK) has filed a Form 144 indicating an intention to sell restricted securities under Rule 144.
The notice covers 40,000 shares of the company’s Series C common stock with an aggregate market value of $1.76 million, to be brokered through UBS Financial Services on or about 18 June 2025 on the NASDAQ market. Outstanding shares of the Series C class are reported at 51,297,110, making the proposed sale roughly 0.08 % of that class.
The filing also discloses that Derek Schiller—listed in the “Securities Sold During the Past 3 Months” table—sold 72,505 shares of the same class on 11 June 2025 for $3.12 million. Together with the new notice, insider sales over the last quarter total 112,505 shares valued at approximately $4.88 million, or about 0.22 % of the outstanding Series C float.
The shares to be sold were acquired via option exercise on 18 June 2025 and paid for in cash, as disclosed under “Nature of Acquisition Transaction.” The filer represents that no undisclosed material adverse information is known, in line with Rule 144 requirements.
Key Takeaways:
- Form 144 signals a potential insider sale but is not, by itself, a commitment to sell.
- The size of the planned sale is small relative to total shares outstanding, suggesting limited direct dilution or market impact.
- Investors may nonetheless monitor continued insider activity for sentiment signals, especially given the recent prior sale by the same insider.